Upcoming Webinar STD-HIV AIDS-2020 | STD-HIV AIDS-2020 2020 | Sexually Transmitted Diseases Conferences

Theme: Honoring Community Engagement through Awareness, Prevention and Care during COVID-19

STD-HIV AIDS-2020

Renowned Speakers

Gary Blick
World Health Clinicians
USA

William Hanna
CY Molecular Diagnostics, Inc., (CYMD)
USA

Arnold Mervyn Levin
University of the Witwatersrand
South Africa

Pedro Brandao dos Santos Pedrosa,
Leibniz University
Germany

Yuan Gu
Capital Medical University
China

Hiroshi Ohrui
Yokohama University of Pharmacy
Japan

Loran J. Thompson,
CEO and Founder of The Wellness Edge Corporate Trainer, Health Coach, National Speaker and Author
USA

Charbell Miguel Haddad Kury
Federal University of Rio de Janeiro
Brazil

Isaac Effiong
Mayo Clinic
USA

Natalia Tschowri
Humboldt-UniversitÃ¤t zu Berlin
Germany

Shen Kunling,
Capital Medical University
China

Christophe Longuet
Fondation Merieux Lyon
France

Charles William Keevil
University of Southampton Centre for Biological Sciences
UK

Amparo Gamero Lluna
University of Valencia
Spain

ZhangLei
Chinese Academy of Agricultural Sciences
China

Shubhada Bopegamage
Slovak Medical University
Slovakia

Segolene Caboche
Lille University of Science and Technology
France

Rajinder S. Ranu
Colorado State University
USA

BoÅ¼ena Futoma-KoÅ‚och
University of WrocÅ‚aw Poland
Poland

Fiona McPhee
Bristol-Myers Squibb Co
USA

Lenore Pereira
University of California San Francisco
USA

Amin Fadl
University of Wisconsin-Madison
USA

Massimo Clementi
University Vita-Salute San Raffaele, Milan
Italy

Angelika Krumina
Riga Stradins University
Latvia

Ulrich Desselberger
University of Cambridge
UK

Gore Gorszewska Gabriela
Jagiellonian University
Poland

Amelie Mc Fadyen
University of Quebec in Montreal
Canada

Francois Dufrasne
Universite Catholique de Louvain
Belgium

Ewa Carlsson-Lalloo
University of Gothenburg
Sweden

Juana DÃez,
Pompeu Fabra University
Spain

Natalie Borg

Australia

STD-HIV AIDS-2020

We cordially invite all the Researchers, Academicians, Students and Business professionals in the field of STD, HIV/AIDS to the “8^th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs” scheduled on June 24-25, 2020 through Webinar. The conference includes prompt Keynote Presentations, Oral Talks, Poster Presentations, Workshops and Exhibitions. As said “Prevention is better than cure”, we also believe that sharing the knowledge and discussing about the field of infectious diseases which have become progressively important to Public Health is the major aspects to which everyone should be aware of.

Why to Attend?

STD-HIV AIDS-2020 Online webinar is intended to honor prestigious award for talented Young researchers, Scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the STD-HIV AIDS-2020 Webinar conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Infectious Diseases.

Young Research’s Awards at STD-HIV AIDS-2020 for the Nomination:

Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation and only 25 presentations acceptable at the STD-HIV AIDS-2020 Online Event.

YRF Registration Benefits:

Young Scientist Award recongination certificate and memento to the winners
STD-HIV AIDS-2020 provides best Platform for your research through oral presentations.
Learn about career improvement with all the latest technologies by networking.
Provide an opportunity for research interaction and established senior investigators across the globe in the field of Infectious Diseases.
STD-HIV AIDS-2020 Online Webinar a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

YRF Registration Deadline

Till April 30 – $399
Till May 28 – $499
Till June 26 – $599

STD-HIV AIDS-2020 Virtual Meeting provides two days discussions on methods and schemes related to “Control and Prevention of HIV/AIDS, STDs & STIs” as well as exploring new ideas and perceptions on a universal scale. This two day event provides a flawless platform for leading Scientists, Researchers, Scholars, Practitioners, Health Care Experts, Treatment providers, Public Health Professionals, and Community health educators, Members of Academia, Allied Health Professionals, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, Social Workers, Student Researchers, Faculties, STD-AIDS Associations and Societies from different part of the countries.

Top Reasons to attend Webinar:

World Class Speakers and Fresh New Talent from across the World in Health Industry.
Packed Schedule: Workshops, Multi-track Conference, Expo Area and more.
To educate yourself on the diagnosis and treatment of STD and Infectious infections.
Enhance your skill to treat the growing number of patients affected by these infections.
To network with your fellow primary care clinicians.
To empower yourself to fill the void created by the national shortage of participants.

STD-HIV/AIDS-2020 is themed “Honoring Community Engagement through Awareness, Prevention and Care during COVID-19”. This focuses knowledge and research in the field of HIV/AIDS, STDs, STIs and other infectious diseases.

Target Audience-

Immunologists
Radiologists
Microbiologists
Bacteriologists
Virologists
STD-AIDS associations and societies
Epidemiologists
Public Health care Professionals
Research scholars
Medical colleges
Infectious Diseases Researchers
Viral Diseases Researchers
Nursing care Professionals

Acquired Immuno Deficiency Syndrome is a syndrome caused by a virus called HIV (Human Immunodeficiency Virus). The disease alters the immune system, making people much more vulnerable to infections and diseases. This susceptibility worsens as the syndrome progresses.

HIV is found throughout all the tissues of the body but is transmitted via the body fluids of an infected person (semen, vaginal fluids, blood, and breast milk). HIV is the virus, which attacks the T-cells (CD-4 cells) in the immune system. AIDS is the syndrome, which appears in the advanced stage of HIV infection.

STDs are infections that are passed from one person to another during vaginal, anal, and oral sex. They’re really common, and lots of people who have them don’t have any symptoms. STDs can be dangerous, but the good news is that getting tested is no big deal, and most STDs are easy to treat.

For Scientific Sessions please go through the link: https://globalhiv-aids-std.infectiousconferences.com

For Abstract Submission please go through the linkhttps://globalhiv-aids-std.infectiousconferences.com/abstract-submission.php

Track 1: Sexually Transmitted Diseases

Sexually transmitted diseases (STDs) are also known as sexually transmitted infections (STIs) or venereal diseases (VD) which are infections that are passed from one person to another through sexual contact. STDs are generally caused by bacteria, parasites, yeast, and viruses. There are more than 20 types of STDs where both men and women are affected but in several cases the health complications, they cause can be more severe for women. If a pregnant woman has an STD, it can cause severe health complications for the baby. Antibiotics can treat STDs produced by bacteria, yeast, or parasites. There is no cure for STDs initiated by a virus, but medications can often help with the symptoms and keep the infection under control.

Relevant Conferences:

9^th International Conference on Tropical Medicine and Infectious Diseases, February 24-25, 2020, Berlin, Germany; 7^th International Congress on Infectious Diseases, February 24-25, 2020, Berlin, Germany; 8^th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs, June 24-25, 2020, Webinar; 15^th World Congress on Infection Prevention and Control, September 16-17, 2020, Dubai, UAE; 12^th Euro-Global Conference on Infectious Diseases, October 05-06, 2020, Vienna, Austria; 10^th International Conference on Emerging Infectious Diseases, November 23-24, 2020, Rome, Italy; 8^th International Conference on HIV AIDS STD & STIs, March 11-12, 2020, Barcelona, Spain; 5^th International Conference & Expo on HIV & AIDS, February 20-21, 2020, Philadelphia, USA; 19^th International Congress on Infectious Diseases, February 20-23, 2020, Kuala Lumpur, Malaysia; Conference on Retroviruses and Opportunistic Infections, March 08-11, 2020, Boston, USA; 10^th International AIDS Society on HIV Science Conference, July 06-10, 2020, San Francisco and Oakland, USA; 4^thBiennial HIV Research for Prevention (HIVR4P) Conference, October 11-15, 2020, Cape Town, South Africa.

Related Societies:

Europe: European AIDS Clinical Society / EACS BELGIUM, AIDS Action Europe Berlin, Germany, International AIDS Society, Switzerland, National Association of People Living With HIV/AIDS, European AIDS Clinical, UNAIDS, BHIVA, Deutsche AIDS Gesellschaft, German, International Union against Sexually Transmitted Infections (IUSTI), European Society for Immunodeficiencies, Association of Nurses in AIDS Care

USA: HIV.gov, USA, National AIDS Commission, HIV Medicine Association, American Sexually Transmitted Diseases Association (ASTDA), International Society for Infectious Diseases, Centers for AIDS Research (CFAR), Canadian Public Health Association, American Sexually Transmitted Diseases Association (ASTDA)

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 2: Clinical Research and Case Reports

STD’s clinical research help scientists find improved ways to prevent, detect, or treat HIV/AIDS and other sexually transmitted diseases. All the medications used to treat HIV/AIDS in the United States were first studied in clinical trials. HIV/AIDS clinical studies under way include studies of new medicines to inhibit or treat HIV, studies of vaccines to prevent or treat HIV, studies of medicines to treat infections correlated to HIV. Case report is the detailed information of the individual patient containing the symptoms, signs, diagnosis, and treatment and follows up of the patient. It is a demographic profile that usually describes an unusual or novel occurrence.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 3: Immunology and Vaccine Development

Immunology is the study of the immune systems which contextualizes the: physiological functioning of the immune system in case of both health and diseases; identify the malfunctions of the immune system in immunological disorders (such as autoimmune diseases, hypersensitivities immune deficiency, and transplant rejection; and also include the physical, chemical and physiological characteristics of the components of the immune system. Vaccine is a biological preparation which contains an agent that resembles a disease causing micro-organism and is often made from weekend or dead form of micro-organisms, its toxins or its surface proteins.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 4: Diagnosis and Treatment

Diagnosis is the process of identification of the nature and cause of a particular phenomenon. HIV is generally diagnosed by testing your blood or saliva for antibodies against virus. Inappropriately, it takes time for your body to progress these antibodies usually up to 12 weeks. A faster test checks for the presence of HIV antigen, a protein produced by the virus instantaneously after infection. Treatment refers to the application of medicines, surgery or psychotherapy to a patient or to a disease or symptom. Treatment outcomes were similar across different subgroups, regardless of age, sex, race, baseline viral load, and baseline CD4+ cell count1. Treatment of HIV/AIDS includes mapping and maintaining surveillance of risk behaviors, STIs, and HIV infection.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 5: Transmission and Prevention

Transmission is the process of passing a disease or a disease causing pathogen from an infected host individual or a group of infected people to a particular individual or a group of persons regardless whether they are previously infected or not. Prevention is the application of scientific methodologies in order to prevent or moderate major human dysfunctions before they occur. The Centers for Disease Control and Prevention has introduced different strategies for reducing the STD risk which include: vaccination, mutual monogamy, reducing the number of sexual partners and abstinence. The most effective way to prevent sexual transmission of STIs, HIV / AIDS is to avoid the contact of body parts or fluids which can lead to transfer with an infected partner.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 6: Testing and Health Monitoring

Health monitoring is the way of checking if the health of the particular individual is being harmed from exposure to various disease causing micro-organisms which aims to detect early signs of ill health or disease. The health monitoring includes numerous tests for determining the health of an individual. You can use the health monitor to create a collection of tests, referred to as a health policy, and apply the health policy to one or more appliances. HIV testing refers to shows whether a person has HIV or not. The Centers for Disease Control and Prevention (CDC) recommends that everyone between the 13 to 64 years old get tested for HIV at least once and that people at high risk of infection get tested more often.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 7: Co-infections Associated with STD

Co-infections are the simultaneous infections of a host by multiple pathogen species. There are different co-infections that are associated with STD especially with HIV which leads to lethal condition and worsens the condition of the individual. Co-infection is of particular human health importance because these pathogen species can interact within the host. The net effect of the co-infection on human health is thought to be negative but these Interactions can have either positive or negative effects on other parasites. Under positive parasite interactions, disease transmission and progression are enhanced which is also known as syndemism and in negative parasite interactions include microbial interference when one bacterial species suppresses the virulence or colonisation of other bacteria.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 8: Global Epidemiology and Outbreaks

Epidemiology is the study of analysis and distribution of determinants of health and diseased conditions in a defined population. Major areas of the epidemiological study include disease causation, transmission, outbreak investigation, disease surveillance, forensic epidemiology, occupational epidemiology, screening, biomonitoring, and comparisons of treatment effects such as in clinical trials. They rely on other scientific disciplines such as biology for the better understanding of the disease processes, statistics to make efficient use of the data and draw appropriate conclusions, social sciences for the better understanding proximate and distal causes, and engineering for exposure assessment.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 9: Recent Advancements

The exploration for a preventive immunization that can stop the worldwide pandemic is a definitive objective of HIV research. Expansion of an immunization against HIV-1 has been tormented by various weird difficulties. Distinctive immunization concepts have been tried to overcome these difficulties. Trial immunizations that indicated guarantee in preclinical trials were progressed into clinical trials. However, human trials turned out to be an enormous dissatisfaction until the aftereffects of the RV144 trial in Thailand. Urine tests can be used to check for urethritis in both sexual orientations. Late urination will have washed gonorrheal discharge from the urethra. Vaginal swab illustrations are used to test for cervicitis. Gonorrheal cervicitis produces adequate discharge that swabs need not be taken by speculum inspection.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 10: Health Services and Systems

Health system or health care systems is the organization of people, institutions, and resources that deliver health care services to meet the health needs of target populations. There are a lot of health care systems with many histories and organizational structures of the nations which are designed based on their needs and resources constrained to that nation. Besides there is a concerted effort among governments, trade unions, charities, religious organizations, or other coordinated bodies to deliver planned health care services targeted to the populations they serve. Health services is a multidisciplinary scientific field that examines the how people get access to the health care practitioners, health care services, costs, and what happens to the patients as a result of this care.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 11: Sexual Health

Sexual health is a state of physical, mental and social well-being of an individual in relation to sexuality. It generally requires a positive and respectful approach to sexuality and sexual relationships, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, discrimination and violence. According to WHO for attaining and maintaining the sexual health, the sexual rights of all persons must be respected, protected and fulfilled.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 12: Social and Legal Issues

The social issues associated with HIV and sexually transmitted diseases can be understood in two ways. Firstly, they social impact might refer to the social determinants of the pandemic and secondly, they relate to the social impact of the pandemic. Ethical questions present some of the most vexing problems associated with HIV infection and sexually transmitted diseases. Ethics cannot be considered in a vacuum. The social context dictates how the principles of ethics are applied and interpreted.

Relevant Conferences:

Related Societies:

USA: HIV.gov, USA, National AIDS Commission, HIV Medicine Association, American Sexually Transmitted Diseases Association (ASTDA),International Society for Infectious Diseases, Centers for AIDS Research (CFAR), Canadian Public Health Association, American Sexually Transmitted Diseases Association (ASTDA)

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS

Track 13: Public Health

Public health is the science of defensive and educating the health of people and their communities. This work is attained by promoting healthy lifestyles, researching disease and injury prevention, and detecting, preventing and responding to infectious diseases. Public health professionals try to avoid problems from happening or recurring through executing educational programs, recommending policies, managing services and conducting research—in contrast to medical professionals like doctors and nurses, who focus mainly on treating individuals after they become sick or injured. Public health also works to limit health differences.

Relevant Conferences:

Related Societies:

Asia Pacific: National AIDS Control Organization, India HIV/AIDS Alliance, SAATHII, St. Maarten AIDS Foundation, Australian Federation of AIDS Organizations, AIDS SOCIETY OF INDIA, IASSTD & AIDS.

Conference Series LLC Ltd is delighted to invite all intended participants to attend “8^thWorld Congress on Control and Prevention of HIV/AIDS, STDs & STIs (STD-HIV AIDS 2019)” scheduled on June 24-25, 2020 through webinar. STD-HIV AIDS 2020 online conference is a unique and open platform to discover and gain the knowledge in the field of Life Science. The conference brings together Professors, Researchers, Scientists, Practitioners, Health Care Experts, Public Health Professionals and Students from all the zones of Medical Sciences. It will offer an exciting scientific program, composed of Plenary Lectures, Poster Presentation, Workshops and Abstract-driven sessions presenting the latest research in the field of HIV/AIDS. Furthermore, STD-HIV AIDS 2020 webinar will also provide an opportunity for young investigators to participate actively and present their research.

For more details please visit: https://globalhiv-aids-std.infectiousconferences.com

About STD-HIV AIDS:

STDs are infections that are spread from one person to another during vaginal, anal, and oral sex. STDs produced by bacteria, yeast, or parasites can be treated by Antibiotics. There is no cure for STDs initiated by a virus, but medicines can often help with the symptoms and keep the infection under control. Human immuno deficiency virus it damages your immune system by destroying the white blood cells that fight infection. AIDS stands for Acquired Immuno-Deficiency Syndrome, which appears in the progressive stage of HIV infection.

Antiretroviral therapy (ART) is recommended to treat HIV infection. People on ART take a combination of HIV medications every day. ART can’t cure HIV infection, but HIV medicines help individuals with HIV live longer, healthier lives. HIV medicines can also decrease the risk of HIV transmission.

HIV diagnostics market size was valued at USD 2.9 billion in 2017 and is expected to witness 8.7% CAGR from 2018 to 2024.

Increasing prevalence of HIV infection worldwide will majorly boost HIV diagnostics market growth over the forecast period. HIV infection is one of the leading causes of morbidity and mortality. As per the UNAIDS’s data more than 36.7 million people across the globe were living with HIV in 2017. Around 1.8 million children aged below 15 years had HIV infection. Additionally, many were infected by their HIV-positive mothers during pregnancy, child birth or breast-feeding. Growing incidences of AIDS especially in the developing and underdeveloped economies will offer several growth opportunities in HIV diagnostics resulting in industry growth.

HIV Drug Market Analysis

Human immunodeficiency virus (HIV) is one of the most infectious diseases with around 36.7 million people suffering by the end of 2015, according to The Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV Drug Market was valued at $20,448 million in 2015 and is expected to garner $26,458 million by 2022. In 2017 the global HIV drugs market exceeded a value of US$ 17 Billion. Looking forward, the market value is expected to reach nearly US$ 21 Billion by 2023, expanding at a CAGR of more than 3% during 2018-2023.

HIV Infected Death Rate:

Situation and trends

770 000 [570 000−1 100 000] people died of HIV-related illnesses worldwide in 2018. Expanded access to antiretroviral therapy (ART) and a declining incidence of HIV infections have led to a steep fall globally in the number of adults and children dying from HIV-related causes. The estimated 770 000 [570 000−1 100 000] people dying from HIV globally in 2018 were 56% fewer than in 2004 (the peak) and 33% fewer than in 2010 in spite of a period of substantial population growth in many high burden countries.

Nevertheless, there is no room for complacency. Countries need to live up to their commitment to end the AIDS epidemic as a public health threat by 2030 -- a target included in the 2030 Agenda for Sustainable Development adopted by the United Nations General Assembly in September 2015. The immediate challenge is to reach the Fast-Track targets for 2020, as HIV-related deaths are still unacceptably high.

Global Data:

Since the beginning of the HIV epidemic, more than 70 million individuals were infected approximately with the HIV virus and about 35 million people died of HIV. Universally, 36.9 million [31.1–43.9 million] people are living with HIV at the end of 2017. An expected 0.8% [0.6-0.9%] of adults aged 15–49 years affected with HIV, although the burden of the epidemic continues to vary considerably between countries and regions. The WHO African region remains most severely affected, with nearly 1 in every 25 adults (4.1%) living with HIV and accounting for nearly two-thirds of the people living with HIV worldwide.

Major STD-HIV/AIDS Associations around the Globe:

European AIDS Clinical Society / EACS BELGIUM
AIDS Action Europe Berlin
Germany, International AIDS Society, Switzerland
European AIDS Clinical
United Nations Programme on HIV and AIDS (UNAIDS)
British HIV Association (BHIVA)
Deutsche AIDS Gesellschaft, German
International Union against Sexually Transmitted Infections (IUSTI)
European Society for Immunodeficiencies
Association of Nurses in AIDS Care
HIV.gov, USA
National AIDS Commission
HIV Medicine Association
American Sexually Transmitted Diseases Association (ASTDA)
International Society for Infectious Diseases
Centers for AIDS Research (CFAR)
Canadian Public Health Association
American Sexually Transmitted Diseases Association (ASTDA)
National AIDS Control Organisation
India HIV/AIDS Alliance
Solidarity and Action Against the HIV Infection in India (SAATHII)
St. Maarten AIDS Foundation
Australian Federation of AIDS Organisations
AIDS SOCIETY OF INDIA
Indian Association for the Study of Sexually Transmitted diseases (IASSTD) & AIDS

STD-HIV AIDS Research Universities:

University of Cardenal Herrera, Spain
University of Santiago de Compostela, Spain
University Hospital Marqués de Valdecilla, Spain
University of Maryland Medical Center, Spain
University of Liverpool-Institute of Infection and Global Health, Spain.
Universitat Autònoma de Barcelona
University of Barcelona, Spain
University of Oxford, United Kingdom
Generalitat de Catalunya, Spain
University of Malaga, Spain
University of Cukurova, Turkey
Goethe University Frankfurt, Germany
University of British Columbia, Canada
Texas A&M University- Veterinary Medicine and Biomedical Sciences, USA
Brown University-Spain
National Institute for Infectious Diseases Lazzaro Spallanzani, Italy
San Raffaele Scientific Institute, Italy
University of the Balearic Islands, Spain
University of Cantabria, Spain
University of Cadiz, Spain
University of Jaen, Spain
Pompeu Fabra University, Spain
Duke University, USA
Northwestern University
Emory University
Harvard University
University of Rochester Medical Center
UCL Institute of Epidemiology and Health care
University of California
Baylor College of Medicine
University of Alabama
University of Pennsylvania
Beth Israel Medical Center
Newyork University
University of Liverpool
University of Colorado Denver
Imperial College London

Pharma Companies:

For more details please visit: https://globalhiv-aids-std.infectiousconferences.com/

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	June 24-25, 2020
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View